Evropska unija - latvijščina - EMA (European Medicines Agency)

novartis vaccines and diagnostics s.r.l. - influenza virus surface antigens (haemagglutinin and neuraminidase) of strain: a/california/7/2009 (h1n1)-derived strain used nymc x-181 - influenza, human; immunization; disease outbreaks - influenza vaccines - a (h1n1v) 2009 vīrusa izraisīta gripas profilakse. focetria būtu jāizmanto saskaņā ar oficiālās vadlīnijas.

Evropska unija - latvijščina - EMA (European Medicines Agency)

actavis group ptc ehf - sildenafil - erektilā disfunkcija - uroloģiskie līdzekļi - Ārstēšana ar vīriešiem ar erektilo disfunkciju, proti, nespēja sasniegt vai uzturēt dzimumlocekļa erekciju, kas ir pietiekama, lai nodrošinātu apmierinošu seksuālo darbību. lai sildenafila actavis būtu efektīva, seksuālo stimulāciju ir vajadzīgs.

Evropska unija - latvijščina - EMA (European Medicines Agency)

seqirus netherlands b.v. - a/darwin/6/2021(h3n2)-like strain (a/darwin/11/2021, wild type) / a/wisconsin/67/2022 (h1n1)pdm09-like strain (a/georgia/12/2022 cvr-167) / b/austria/1359417/2021-like strain (b/singapore/wuh4618/2021) / b/phuket/3073/2013-like virus (b/singapore/inftt-16-0610/2016, wild type) - gripas, cilvēka - gripas vakcīna, inaktivēta, šķelta viriona vai virsmas antigēna - prophylaxis of influenza in adults and children from 2 years of age. flucelvax tetra būtu jāizmanto saskaņā ar oficiālās rekomendācijas.

Evropska unija - latvijščina - EMA (European Medicines Agency)

siga technologies netherlands b.v. - tecovirimat - poxviridae infections; cowpox; monkeypox; vaccinia; smallpox - pretvīrusu līdzekļi sistēmiskai lietošanai - tecovirimat siga is indicated for the treatment of the following viral infections in adults and children with body weight at least 13 kg:- smallpox- monkeypox- cowpoxtecovirimat siga is also indicated to treat complications due to replication of vaccinia virus following vaccination against smallpox in adults and children with body weight at least 13 kg (see sections 4. 4 un 5. tecovirimat siga should be used in accordance with official recommendations.

Evropska unija - latvijščina - EMA (European Medicines Agency)

merck europe b.v. - tepotinib hydrochloride monohydrate - karcinoma, nesīkšūnu plaušas - antineoplastiski līdzekļi - tepmetko as monotherapy is indicated for the treatment of adult patients with advanced non-small cell lung cancer (nsclc) harbouring alterations leading to mesenchymal-epithelial transition factor gene exon 14 (metex14) skipping, who require systemic therapy following prior treatment with immunotherapy and/or platinum-based chemotherapy.

Evropska unija - latvijščina - EMA (European Medicines Agency)

novartis europharm limited  - gozetotide - radionuklīdu attēlveidošana - diagnostikas radiofarmaceitiskie preparāti - Šīs zāles ir paredzētas tikai diagnostikas vajadzībām. locametz, after radiolabelling with gallium 68, is indicated for the detection of prostate specific membrane antigen (psma) positive lesions with positron emission tomography (pet) in adults with prostate cancer (pca) in the following clinical settings:primary staging of patients with high risk pca prior to primary curative therapy,suspected pca recurrence in patients with increasing levels of serum prostate specific antigen (psa) after primary curative therapy,identification of patients with psma positive progressive metastatic castration resistant prostate cancer (mcrpc) for whom psma targeted therapy is indicated (see section 4.

Evropska unija - latvijščina - EMA (European Medicines Agency)

novartis europharm limited  - lutetium (177lu) vipivotide tetraxetan - prostatas audzējiem, kastrācija-izturīgs - terapeitiskie radiofarmaceitiskie preparāti - pluvicto in combination with androgen deprivation therapy (adt) with or without androgen receptor (ar) pathway inhibition is indicated for the treatment of adult patients with progressive prostate-specific membrane antigen (psma)-positive metastatic castration-resistant prostate cancer (mcrpc) who have been treated with ar pathway inhibition and taxane based chemotherapy.

Latvija - latvijščina - Zāļu valsts aģentūra

teva pharma b.v., netherlands - sildenafils - apvalkotā tablete - 20 mg

Latvija - latvijščina - Zāļu valsts aģentūra

norameda uab, lithuania - sildenafils - apvalkotā tablete - 20 mg

Latvija - latvijščina - Zāļu valsts aģentūra

g.l. pharma gmbh, austria - sildenafils - apvalkotā tablete - 20 mg